Docket
36798
Sandoz Canada Inc., et al. v. Attorney General of Canada, et al.
(Federal) (Civil) (By Leave)
(Sealing order)
Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.
| Date | Proceeding | Filed By (if applicable) |
|---|---|---|
| 2016-09-08 | Close file on Leave | |
| 2016-09-08 | Discontinuance of the application for leave to appeal, (Letter Form), (Printed version filed on 2016-09-08) | Sandoz Canada Inc. |
| 2016-07-27 | Correspondence received from, (Letter Form), Kate Bradley (for the Applicant); dated 2016/07/27 Re: Volume III of the application for leave to appeal is not sealed., (Printed version filed on 2016-07-27) | Sandoz Canada Inc. |
| 2016-06-27 | Correspondence received from, (Letter Form), Jeffrey Beedell dated 2016-06-27. Re: Filing of a supplemental authority (2016 FC 716) | Alexion Pharmaceuticals Inc. |
| 2016-06-27 | All materials on application for leave submitted to the Judges, Cro Wa Côt | |
| 2016-06-27 | Submission of motion for leave to intervene, Cro Wa Côt | |
| 2016-06-09 | Correspondence received from, Kate Bradley dated 2016-06-09. Re: Change of address for counsel of the applicants | Sandoz Canada Inc. |
| 2016-02-22 | Reply to the motion for leave to intervene., Completed on: 2016-02-22 | Alexion Pharmaceuticals Inc. |
| 2016-02-18 | Applicant's reply to respondent's argument, Completed on: 2016-02-18 | Sandoz Canada Inc. |
| 2016-02-15 | Response to the motion for leave to intervene, (Letter Form), Completed on: 2016-03-07 | Sandoz Canada Inc. |
| 2016-02-11 | Response to the motion for leave to intervene, (Letter Form), Completed on: 2016-02-11, (Electronic version filed on 2016-02-11) | Attorney General of Canada |
| 2016-02-08 | Correspondence received from, (Letter Form), from counsel for the AG dated 2016-02-08 re: the sealed documents in the response, (Electronic version filed on 2016-02-08) | Attorney General of Canada |
| 2016-02-08 | Respondent's response on the application for leave to appeal, (Book Form), (2 volumes), Volume 2 is sealed, Completed on: 2016-02-08, (Electronic version filed on 2016-02-08) | Attorney General of Canada |
| 2016-02-08 | Certificate (on limitations to public access), (Letter Form), amended version filed 2016-02-09, (Electronic version filed on 2016-02-08) | Attorney General of Canada |
| 2016-02-04 | Motion for leave to intervene, (Book Form), Completed on: 2016-02-04, (Electronic version filed on 2016-02-04) | Alexion Pharmaceuticals Inc. |
| 2016-01-25 | Correspondence received from, (Letter Form), from counsel for the respondent, (Printed version filed on 2016-01-25) | Attorney General of Canada |
| 2016-01-14 | Notice of name, (Letter Form), (Electronic version filed on 2016-01-14) | Sandoz Canada Inc. |
| 2016-01-08 | Letter acknowledging receipt of a complete application for leave to appeal, file opened 2016-01-08 | |
| 2016-01-05 | Book of authorities, (Book Form) | Sandoz Canada Inc. |
| 2016-01-05 | Certificate (on limitations to public access), (Letter Form), amended certificate received 2016-02-01 | Sandoz Canada Inc. |
| 2016-01-05 | Application for leave to appeal, (Book Form), (4 volumes), Volumes 2 and 4 are sealed. 6 redacted copies of volumes 2 and 4 were filed 2016-01-26., Completed on: 2016-01-05 | Sandoz Canada Inc. |
- Date modified: